C12N 2502/00
Coculture with
Official title: Coculture with; Conditioned medium produced by
C12N2502/00 (Coculture with) appears on 2,393 US grants and 4,761 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,393
- Published applications
- 4,761
- Assignees
- 1,798
- Inventors
- 7,767
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 4 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 7 | 0 |
| 1994 | 4 | 0 |
| 1995 | 15 | 0 |
| 1996 | 22 | 0 |
| 1997 | 25 | 0 |
| 1998 | 42 | 0 |
| 1999 | 35 | 0 |
| 2000 | 36 | 0 |
| 2001 | 42 | 19 |
| 2002 | 29 | 86 |
| 2003 | 40 | 101 |
| 2004 | 21 | 99 |
| 2005 | 31 | 116 |
| 2006 | 32 | 102 |
| 2007 | 23 | 118 |
| 2008 | 34 | 112 |
| 2009 | 40 | 125 |
| 2010 | 64 | 153 |
| 2011 | 53 | 155 |
| 2012 | 92 | 157 |
| 2013 | 64 | 141 |
| 2014 | 108 | 163 |
| 2015 | 99 | 167 |
| 2016 | 86 | 189 |
| 2017 | 105 | 212 |
| 2018 | 129 | 229 |
| 2019 | 142 | 261 |
| 2020 | 118 | 284 |
| 2021 | 145 | 312 |
| 2022 | 134 | 368 |
| 2023 | 130 | 317 |
| 2024 | 154 | 323 |
| 2025 | 152 | 251 |
| 2026 | 112 | 201 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2502/13Connective tissue cellsIndexing code919
- C12N 2502/11Blood or immune system cellsIndexing code746
- C12N 2502/28Vascular endothelial cellsIndexing code234
- C12N 2502/99Genetically modified cellsIndexing code225
- C12N 2502/09Epidermal cells, skin cells, oral mucosa cellsIndexing code208
- C12N 2502/02Embryonic cellsIndexing code187
- C12N 2502/30Tumour cellsIndexing code172
- C12N 2502/08Cells of the nervous systemIndexing code163
All 20 subgroupsShow fewer
- C12N 2502/14HepatocytesIndexing code70
- C12N 2502/24Genital tract cells, non-germinal cells from gonadsIndexing code55
- C12N 2502/25Urinary tract cells, renal cellsIndexing code55
- C12N 2502/27Lung cells, respiratory tract cellsIndexing code33
- C12N 2502/23Gastro-intestinal tract cellsIndexing code31
- C12N 2502/45Artificially induced pluripotent stem cellsIndexing code27
- C12N 2502/70Non-animal cellsIndexing code25
- C12N 2502/03Non-embryonic pluripotent stem cellsIndexing code23
- C12N 2502/50Invertebrate cellsIndexing code21
- C12N 2502/22Pancreatic cellsIndexing code17
- C12N 2502/04Germ cellsIndexing code16
- C12N 2502/07Endocrine cellsIndexing code6
Recent patents
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith6 Oct 2026US 12,753,392 B2SymbioCellTech, LLC
- Suppression of diabetes using exosomes from stem cell programmed myeloid cells22 Sep 2026US 12,741,015 B2Creative Medical Technologies, Inc.
- Methods of bioengineering internal anal sphincter constructs22 Sep 2026US 12,741,058 B2Wake Forest University Health Sciences
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Chimeric antigen receptors with CD20 safety switch22 Sep 2026US 12,742,001 B2St. Jude Children?S Research Hospital
- Cd4+ cytotoxic t cells and methods of use thereof8 Oct 2026US 2026/0308522 A1Dana-Farber Cancer Institute, Inc.
- Methods of enhancing or modifying nk cells8 Oct 2026US 2026/0308525 A1Zelluna Immunotherapy AS
- Chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy8 Oct 2026US 2026/0308537 A1The Scripps Research Institute
- Use of 2-pentanone and specific receptor thereof in manufacture of products regulating cell functions1 Oct 2026US 2026/0297006 A1Creator (Wuhan) Medicine Technology Co., Ltd.
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
Most cited
By later US patents
- Primate embryonic stem cells641US 5,843,780 AWisconsin Alumni Research Foundation · 1998
- Primate embryonic stem cells497US 6,200,806 B1Wisconsin Alumni Research Foundation · 2001
- Human hematopoietic stem cell388US 5,061,620 ASystemix, Inc. · 1991
- CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies343US 6,410,319 B1City of Hope · 2002
- Chimeric receptors with 4-1BB stimulatory signaling domain329US 8,399,645 B2St. Jude Children?S Research Hospital · 2013